"Yanshengchao" completed hundreds of millions of yuan in Series A financing.

36Kr learned that "Yanshengchao" successfully completed a Series A financing of hundreds of millions of RMB. This round of financing was exclusively led by Cathay Capital, with investment institutions such as SDIC Venture Capital following suit. The old shareholder, Qiming Venture Partners, continued to support for the fourth consecutive round. The funds raised in this round will be mainly used to support the clinical development of the core pipeline YSC001, the pre - clinical development of YSC002, the early verification work of YSC003/YSC004, and further expand the company's international strategic layout and deepen business development cooperation with top multinational pharmaceutical companies.